Resonate Blends, Inc. (OTCPK: KOAN)
Health Care · Pharmaceuticals · US
$0.00
-20.00% today · -93.2% 1Y
Resonate Blends, Inc. (OTCPK: KOAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $156.11K and employs 2 people.
Over the last twelve months the share price has lost 93.2%, trading between 0.00 and 0.02.
Tweenvest scores Resonate Blends, Inc. across four factors: quality 9/100, value 53/100. Its strongest factor is value.
KOAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $156.11K
- Revenue (TTM)
- $2.23M
- P/E
- 0.04
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- 3.62
- 52-week high
- $0.02
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 390.26M
- Employees
- 2
- Next earnings
- —
About Resonate Blends, Inc.
APOLLO BioWellness Inc. focuses its efforts on researching, formulating, and bringing to market products designed for human health within the regenerative medicine sector. A significant part of its operations involves the commercialization of licensed, naturally derived compounds currently awaiting patent approval, which are specifically engineered to boost an individual's innate capacity to mobilize adult stem cells from their own bone marrow. Additionally, the firm possesses the marketing rights for an all-natural, two-pronged dietary supplement crafted to help regulate hunger by engaging the body's intrinsic signaling pathways between the brain and the digestive system. Beyond its current offerings, the company is also deeply involved in research and development initiatives. These efforts are dedicated to exploring new frontiers, such as Secretogues aimed at enhancing a person's endogenous growth hormone synthesis, along with other natural bioactive formulations intended to optimize human physiological performance. This is achieved by harnessing the body's own biological mechanisms, entirely without the use of pharmaceutical drugs. The company maintains its corporate headquarters in North Bergen, New Jersey.
- ISIN
- US76090M1027
- Listed since
- Mar 31, 1993
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,233.66 | -1.06% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $273.14 | +0.04% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $156.45 | +3.84% |
| Roche Holding AGSWX: ROP | $371.62B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.57 | +2.15% |
Figures last refreshed Aug 18, 2026.